Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Neuraxis Metastases Of Primary Central Nervous System Tumors: A Review Of Clinicopathological And Radiographic Characters Of 198 Cases In A Single Center.

Liu H, Zhang J, Liu Y, Sun Y, Li C, Gu C, Wang H, Zhang H, Yu C, Zhang M.

Cancer Manag Res. 2019 Nov 20;11:9829-9841. doi: 10.2147/CMAR.S217672. eCollection 2019.

2.

Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy.

Kellie SJ, Kovnar EH, Kun LE, Horowitz ME, Heideman RL, Douglass EC, Langston JW, Sanford RA, Jenkins JJ 3rd, Fairclough DL.

Cancer. 1992 Feb 15;69(4):1061-6.

PMID:
1735073
3.
4.

Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.

Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H.

Cancer. 1994 Aug 15;74(4):1383-97.

PMID:
8055462
6.

Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.

Suki D, Khoury Abdulla R, Ding M, Khatua S, Sawaya R.

J Neurosurg Pediatr. 2014 Oct;14(4):372-85. doi: 10.3171/2014.7.PEDS13318. Epub 2014 Aug 15.

PMID:
25127097
7.

Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Dinnes J, Ferrante di Ruffano L, Takwoingi Y, Cheung ST, Nathan P, Matin RN, Chuchu N, Chan SA, Durack A, Bayliss SE, Gulati A, Patel L, Davenport C, Godfrey K, Subesinghe M, Traill Z, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.

Cochrane Database Syst Rev. 2019 Jul 1;7:CD012806. doi: 10.1002/14651858.CD012806.pub2.

PMID:
31260100
8.

Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.

Terterov S, Krieger MD, Bowen I, McComb JG.

J Neurosurg Pediatr. 2010 Aug;6(2):131-6. doi: 10.3171/2010.5.PEDS09333.

PMID:
20672933
9.

Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.

Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio K, Hortobagyi GN, Rivera E.

Cancer. 2007 Dec 15;110(12):2640-7.

10.

[Medulloblastoma with extracentral nervous system metastases: clinical presentation and risk factors].

Kochbati L, Bouaouina N, Hentati D, Nasr C, Besbes M, Benna F, Boussen H, Maalej M.

Cancer Radiother. 2006 May;10(3):107-11. French.

PMID:
16600659
11.

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.

Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, et al.

J Clin Oncol. 1990 Feb;8(2):330-6. Review.

PMID:
2153766
12.

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA.

Lancet Oncol. 2018 Jun;19(6):768-784. doi: 10.1016/S1470-2045(18)30204-3. Epub 2018 May 16.

13.

Neoplastic meningitis.

Kim L, Glantz MJ.

Curr Treat Options Oncol. 2001 Dec;2(6):517-27. Review.

PMID:
12057097
14.

Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II trial.

Allen JC, Helson L, Jereb B.

Cancer. 1983 Dec 1;52(11):2001-6.

PMID:
6627214
15.

Gestational trophoblastic disease metastatic to the central nervous system.

Evans AC Jr, Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez GC, Hammond CB.

Gynecol Oncol. 1995 Nov;59(2):226-30.

PMID:
7590478
16.

Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management.

Kraetzig T, McLaughlin L, Bilsky MH, Laufer I.

J Neurosurg Spine. 2018 Feb;28(2):201-208. doi: 10.3171/2017.5.SPINE161164. Epub 2017 Dec 8.

PMID:
29219779
17.

Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.

Ho VK, Gijtenbeek JM, Brandsma D, Beerepoot LV, Sonke GS, van der Heiden-van der Loo M.

Eur J Cancer. 2015 Nov;51(17):2508-16. doi: 10.1016/j.ejca.2015.07.040. Epub 2015 Aug 12.

PMID:
26277099
18.

Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.

Kellie SJ, Wong CK, Pozza LD, Waters KD, Lockwood L, Mauger DC, White L.

Med Pediatr Oncol. 2002 Sep;39(3):168-74.

PMID:
12210445
19.

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.

Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):795-803. Review.

PMID:
10098435
20.

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.

Kim HJ, Im SA, Keam B, Kim YJ, Han SW, Kim TM, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Noh DY, Heo DS, Park IA, Bang YJ, Ha SW.

J Neurooncol. 2012 Jan;106(2):303-13. doi: 10.1007/s11060-011-0664-8. Epub 2011 Sep 22.

PMID:
21938531

Supplemental Content

Support Center